Delivery Order SPE2DB22D1202-SPE2DB24FUNX9
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., to provide WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a total potential value of $1,074.54 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. This delivery order is part of a larger indefinite delivery contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,695.14, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of October 30, 2023. The contract was awarded on October 27, 2023, and does not have a set-aside designation, indicating open competition....
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.38 firm fixed price delivery order is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The firm-fixed-price contract, valued at $8,618.98, has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The award, valued at $15,095.14, is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of April 29, 2024 and is a Firm Fixed Price (FFP) arrangement. The contract was awarded on April 26, 2024 without any set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,837.72 firm fixed-price delivery order is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication, with a period of performance through June 15, 2023. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,645.62, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the...
- This federal contract award, valued at $1,097.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract involves the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The award has an ultimate completion date of December 29, 2023 and is a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $24,108.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 16, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,583.90 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through March 7, 2024. The contract is a firm-fixed-price type with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant...